Status:
COMPLETED
Partial Rebreathing in the Treatment of Migraine With Aura
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Rehaler
Conditions:
Migraine With Aura
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
A study to test the efficacy of a partial rebreathing device in treating and/or preventing migraine pain
Eligibility Criteria
Inclusion
- \- Migraine with aura
- Attack frequency of between one and six migraine-with-aura attacks per month over the last six months
- Adults (18-60 years)
- Age at onset of migraine \< 50 years
- If taking migraine prophylactic drugs, the dosis must have been stable for \> 3 months
- Must speak and understand Danish
Exclusion
- \- Cardiovascular disease, pulmonary disease, metabolic acid/base disorder, cancer, moderate and severe depression, anemia or other blood disease
- Chronic migraine, i.e. more than 15 headache days per month over the last three months
- Medication overuse headache
- More than six migraine-with-aura attacks per month
- Non-migraine headache on more than six days per month
- A typical duration between migraine-with-aura attacks of less than 48 hours
Key Trial Info
Start Date :
November 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03472417
Start Date
November 1 2016
End Date
September 1 2017
Last Update
March 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pain and Headache Clinic, Aarhus University Hospital
Aarhus, Denmark, 8000